Plunkett Research Online: Chemomab Therapeutics Ltd

CHEMOMAB THERAPEUTICS LTD (CMMB:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Chemomab Therapeutics Ltd. (formerly Chemomab Ltd.) is a clinical-stage biotech company discovering and developing innovative therapeutics for conditions with high unmet medical need that involve inflammation and fibrosis. The company’s novel anti-CCL24 platform hinders the fundamental function of .....



Chemomab Therapeutics Ltd
Ticker: CMMB
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 972-77-3310156
Fax:
Address: Kiryat Atidim
Building 7
Tel Aviv, 6158002 Israel

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Pharmaceuticals Development & Manufacturing
Clinical-Stage Biotechnology
Therapeutic Development
Inflammation
Fibrosis
Contacts Description
Dale Pfost CEO
Donald Marvin CFO/COO/Executive VP
See More
Chemomab Therapeutics Ltd. (formerly Chemomab Ltd.) is a clinical-stage biotech company discovering and developing innovative therapeutics for conditions with high unmet medical need that involve inflammation and fibrosis. The company’s novel anti-CCL24 platform hinders the fundamental function of .....See More See More

Auditor: KPMG
Legal Advisor:
Table could not be created because no data was found
Brands, Divisions and Affiliates Top Salaries
CM-101
Chemomab Ltd
Anchiano Therapeutics Ltd
Other Thoughts Corporate Culture

Apparent Female Officers or Directors: